In 2011, the groups of Elisabetta Dejana and Elisabeth Tournier-Lasserve reported that EC-specific ablation of Ccm2 in mice only led to a CCM phenotype when induced in developmental stages of active angiogenesis [41]. This evidence concerns the gene CCM2 and cerebral cavernous malformation.